Editorial for the Special Issue “Breast Cancer—Therapeutic Challenges, Research Strategies and Novel Diagnostics”
Author:
Affiliation:
1. Department of Gynecology and Obstetrics, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Germany
2. GynPraxis, 91054 Erlangen, Germany
Abstract
Publisher
MDPI AG
Subject
Cancer Research,Oncology
Link
https://www.mdpi.com/2072-6694/15/18/4611/pdf
Reference15 articles.
1. Global burden and trends in premenopausal and postmenopausal breast cancer: A population-based study;Heer;Lancet Glob. Health,2020
2. Dogan, I., Aksoy, S., Cakar, B., Basaran, G., Ercelep, O., Molinas Mandel, N., Korkmaz, T., Gokmen, E., Sener, C., and Aydiner, A. (2023). Demographic and Clinical Features of Patients with Metastatic Breast Cancer: A Retrospective Multicenter Registry Study of the Turkish Oncology Group. Cancers, 15.
3. Gong, C., Liu, C., Tao, Z., Zhang, J., Wang, L., Cao, J., Zhao, Y., Xie, Y., Hu, X., and Yang, Z. (2022). Temporal Heterogeneity of HER2 Expression and Spatial Heterogeneity of 18F-FDG Uptake Predicts Treatment Outcome of Pyrotinib in Patients with HER2−Positive Metastatic Breast Cancer. Cancers, 14.
4. Xie, Y., Du, X., Zhao, Y., Gong, C., Hu, S., You, S., Song, S., Hu, X., Yang, Z., and Wang, B. (2022). Chemotherapy Shows a Better Efficacy Than Endocrine Therapy in Metastatic Breast Cancer Patients with a Heterogeneous Estrogen Receptor Expression Assessed by 18F-FES PET. Cancers, 14.
5. Li, X., Jiang, S., Jiang, T., Sun, X., Guan, Y., Fan, S., and Cheng, Y. (2023). LEM Domain Containing 1 Acts as a Novel Oncogene and Therapeutic Target for Triple-Negative Breast Cancer. Cancers, 15.
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3